Codexis (CDXS) Non-Current Debt (2017 - 2026)
Codexis (CDXS) posted quarterly Non-Current Debt of $40.5 million for Q1 2026, up 38.71% year-over-year from $29.2 million in Q1 2025, and up 0.94% quarter-over-quarter from $40.1 million in Q4 2025.
Codexis (CDXS) Non-Current Debt (2017 - 2026) Analysis & Trends
Codexis' Non-Current Debt history runs 5 years deep, the most recent figure standing at $40.5 million for Q1 2026.
- In Q1 2026, Non-Current Debt rose 38.71% year-over-year to $40.5 million; the TTM figure through Mar 2026 stood at $40.5 million (up 38.71% YoY), while the FY2025 annual figure was $40.1 million, up 38.75% from the prior year.
- Non-Current Debt for Q1 2026 stood at $40.5 million, up from $40.1 million in the prior quarter.
- The five-year high for Non-Current Debt was $40.5 million in Q1 2026, with the low at $28.1 million in Q1 2024.
- The 3-year median for Non-Current Debt is $29.2 million (2025), against an average of $33.7 million.
- Peak annual rise in Non-Current Debt reached 38.81% in 2025, while the deepest fall reached 3.86% in 2025.
- Codexis' Non-Current Debt stood at $28.9 million in 2024, then surged by 38.75% to $40.1 million in 2025, then gained by 0.94% to $40.5 million in 2026.
- Business Quant data shows CDXS's Non-Current Debt at $40.5 million in Q1 2026, $40.1 million in Q4 2025, and $39.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.09 Bn | 131.23 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.66 Bn | 77.66 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 64.86 Bn | 59.67 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.07 Bn | 52.93 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 41.87 Bn | 36.77 Bn | 1.53 Bn | 882.16 Mn |
| 6 | Alnylam Pharmaceuticals | 31.45 Bn | 28.15 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.90 Bn | 9.51 Bn | 668.28 Mn | 360.97 Mn |
| 8 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | 546.77 Mn |
| 9 | Royalty Pharma | 27.28 Bn | 26.45 Bn | - | 8.96 Bn |
| 10 | Codexis | 152.51 Mn | 97.60 Mn | 11.40 Mn | 40.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 40.88 Mn |
| Mar 31, 2026 | 40.48 Mn |
| Dec 31, 2025 | 40.11 Mn |
| Sep 30, 2025 | 39.73 Mn |
| Jun 30, 2025 | 39.37 Mn |
| Mar 31, 2025 | 29.19 Mn |
| Dec 31, 2024 | 28.91 Mn |
| Sep 30, 2024 | 28.63 Mn |
| Jun 30, 2024 | 28.37 Mn |
| Mar 31, 2024 | 28.10 Mn |
| Sep 30, 2018 | 122,000.00 |
| Jun 30, 2018 | 183,000.00 |
| Mar 31, 2018 | 243,000.00 |
| Dec 31, 2017 | 302,000.00 |
| Sep 30, 2017 | 360,000.00 |
| Jun 30, 2017 | 419,000.00 |
| Mar 31, 2017 | 255,000.00 |